US Stock Market Closed

Dashboard

Novus Therapeutics, Inc. (NVUS)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings
Financial Strength

H

Sustainable Growth
Industry Comparison

H

Management & Equity
Analyst Opinion

B

Leverage & Liquidity

H

Fundamental Variables

Rating Performance

FV Performance

About

Novus Therapeutics Inc. engages in the research and development of pharmaceutical products for patients with disorders of the ear, nose, and throat. The company operates under the surfactant and foam platforms. The surfactant platform develops a treatment option for otitis media under OP0201 pipeline. The foam platform is used as a delivery vehicle for drugs to be administered into the ear canals, as well as the nasal and sinus cavities. The company was founded on March 26, 2004 and is headquartered in Irvine, CA.

CEO

Gregory J. Flesher

Employees

8

Industry

-

Sector

-

Headquarters

Irvine

Exchange

NASDAQ

Summary Stats

Market Cap

-

Revenue

-

Net Income

-

EPS

-

Price-to-Earnings

-

Price-to-Book

-

Debt-to-Equity

-

News

Analyst Ratings

Price targets projected by 3 analysts

High

$35.00

Average

$23.37

Low

$8.00

Ratings calculated by 3 analysts

Buy

2

Hold

1

Sell

0

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

XX

xxx

Last Earnings Not Available

Last Earnings

Not Available

Actual

- -

Consensus

-

Report Date

-

Year Ago

-

Year Ago Change %

-

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites